about
The involvement of amino acid side chains in shielding the nickel coordination site: an NMR study.Metal ion uptake from aqueous solution by olive stones: a carbon-13 solid-state nuclear magnetic resonance and potentiometric study.A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions.Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds.Complex formation equilibria of Cu2+ and Zn2+ with Irbesartan and Losartan.Chelating agents for metal intoxication.Different approaches to the study of chelating agents for iron and aluminium overload pathologies.Nutritional iron deficiency: the role of oral iron supplementation.Toxicity of nanoparticles.The meaning of aluminium exposure on human health and aluminium-related diseases.Tungsten or Wolfram: Friend or Foe?Depleted Uranium and Human Health.Chemical features of in use and in progress chelators for iron overload.Novel DFO-functionalized mesoporous silica for iron sensing. Part 2. Experimental detection of free iron concentration (pFe) in urine samples.Gold - Old Drug With New Potentials.An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions.Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives.A family of hydroxypyrone ligands designed and synthesized as iron chelators.Novel DFO-SAM on mesoporous silica for iron sensing. Part I. Synthesis optimization and characterization of the material.Searching for new aluminium chelating agents: a family of hydroxypyrone ligands.Evaluation of a fibre optic device in solution equilibria studies. Application to 3-hydroxybenzoic acid ionization.Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators.Gas chromatography analysis of major free mono- and disaccharides in milk: Method assessment, validation, and application to real samples.Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone.Manganese and cobalt binding in a multi-histidinic fragment.Changes in the characteristics of low affinity GABA binding sites elicited by Ro15-1788.Stress and beta-carbolines decrease the density of low affinity GABA binding sites; an effect reversed by diazepam.Editorial: Applications of Medicinal Bioinorganic Chemistry.Thermodynamic remarks on chelating ligands for aluminium related diseases.Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies.Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions.Interaction of Cu(II) and Ni(II) with Ypk9 protein fragment via NMR studies.Copper-related diseases: From chemistry to molecular pathologySilver coordination compounds: A new horizon in medicineToxicity of Nanoparticles: Etiology and MechanismsAssessment, Validation and Application to Real Samples of an RP-HPLC Method for the Determination of Guayulins A, B, C and D in Guayule ShrubSubstituent effects on ionization constants as a predictive tool of coordinating abilityA Possible Freshness Marker for Royal Jelly: Formation of 5-Hydroxymethyl-2-furaldehyde as a Function of Storage Temperature and TimeFree fluoride determination in honey by ion-specific electrode potentiometry: Method assessment, validation and application to real unifloral samples
P50
Q30673136-9D8C58E8-1E09-4473-B5A1-3F32D014CD06Q31134510-5B74206A-7BC3-42FD-8E72-BFBF72B04B10Q35698528-52E8D0F9-3156-4C47-A267-E5D5A44EC690Q36120540-788249D4-CAB1-4763-9AED-B3EB3ECD6258Q36190787-A40160F4-11F3-4BE6-A45E-E94F31E08E4DQ37997847-06EEC928-BB50-42C2-85D4-A199C906A541Q38055398-C454384E-77F8-47BE-B6DF-F73CDB4A6A7DQ38227411-2EEF90F6-3195-4F4E-930A-B1B0F1FAA03AQ38259254-69D19796-9F75-464C-9145-B323D413797BQ38273094-641E5178-5D87-434F-8AC5-A947616F19E7Q38808404-BAC73328-C366-4BD2-8D04-85A51909C2B8Q38809672-8253BB02-3268-45E8-8C9E-DD24D3AFCA63Q38882824-D02E585A-09D4-44D4-B507-3C8129AE4421Q39183018-94C9DA0B-339D-4CA8-B88B-418FE7C5139FQ39209061-F05988A4-1EC9-4675-9CB9-659298BC60C4Q41427338-C3D68343-8886-4FFD-A18A-B4ABF7D0B0EDQ42713986-63D6864F-5DE2-4759-A87E-82664F0AB5E5Q43149276-3121FE22-E70A-4130-B959-556F34DD46ADQ43972283-C66B42E8-3F91-474E-894F-041CB99E7A0DQ44097288-F5580698-4CE9-4A1A-8D94-F10AAA92B45EQ44703022-365B5AE6-CEDD-4709-A955-B9F375DEC2C7Q44944082-A560CFC9-677E-4B85-A96E-4277465EF615Q46226714-44D6D79E-E786-4BCE-BD4A-8C2FD8F5EA0AQ46477316-25CFD4A6-BDB1-480C-B51C-10EFF72C9820Q46864767-6DD8A751-549C-4CE1-BD1D-943852437D39Q46990744-40ECB0A5-FD44-4426-8499-8925245298A3Q48534458-00ED4415-F941-490A-9542-6E18F2B79DA2Q48646539-1DD3C8D9-DCB4-4119-9D3B-02E48FB1FD3CQ49600260-B51C1993-7042-435F-98B6-13064FF3B54BQ51494955-CDF43270-9C6A-478C-B33B-7C6169B989D9Q52312221-A7CF3733-F74C-4EA9-8D33-C1E7C039955BQ52696614-E9BD2BE7-8B31-4644-A12E-0547C2867287Q54355582-6B476B99-BB15-4641-8459-043E57F2735CQ55884385-AA83559A-840F-4F1A-8FA7-644C6CBEDAA2Q56138480-2D17E94C-AB68-42E4-827B-83FD441A1FE0Q56483164-93D18231-5BCC-4CC0-8F63-7F44770A7F1CQ57251570-FB85EF21-3067-4AB4-9004-92DA4807B3BEQ57251579-9EA89729-197C-47BA-85D0-C23B7465C301Q57251580-87DE31E0-21CF-459C-A497-9EC9A5050467Q57251585-AB8F110E-F02C-4F05-A0F4-A92127386DFB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Valeria M. Nurchi
@ast
Valeria M. Nurchi
@en
Valeria M. Nurchi
@es
Valeria M. Nurchi
@nl
Valeria M. Nurchi
@sl
type
label
Valeria M. Nurchi
@ast
Valeria M. Nurchi
@en
Valeria M. Nurchi
@es
Valeria M. Nurchi
@nl
Valeria M. Nurchi
@sl
prefLabel
Valeria M. Nurchi
@ast
Valeria M. Nurchi
@en
Valeria M. Nurchi
@es
Valeria M. Nurchi
@nl
Valeria M. Nurchi
@sl
P1053
E-6216-2013
P106
P1153
6602746087
P21
P31
P3829
P496
0000-0002-4004-1988